Literature DB >> 12010460

Role of Rab5 in the recruitment of hVps34/p150 to the early endosome.

James T Murray1, Christina Panaretou, Harald Stenmark, Marta Miaczynska, Jonathan M Backer.   

Abstract

PI 3-kinases are important regulators of endocytic trafficking. We have previously proposed a model in which the Rab5 GTPase recruits EEA1 to the early endosome both directly, by binding to EEA1, and indirectly, through the recruitment of the p150/hVps34 PI 3-kinase and the production of PI[3]P in the endosomal membrane. In this study we have examined this model in vivo. We find that both endogenous hVps34 and p150 are targeted to enlarged endosomal structures in cells expressing constitutively activated Rab5, where they are significantly colocalized with EEA1. Recombinant fragments of p150 disrupt the endosomal localization of EEA1, showing that p150 is required for EEA1 targeting. We further analyzed the mechanism of GTP-dependent Rab5-p150 binding, and showed the p150 HEAT and WD40 domains are required for binding, whereas deletion of the protein kinase domain increases binding to Rab5. Overexpression of constitutively active Rab5 caused a redistribution of epitope-tagged hVps34 and p150 to Rab5-positive endosomes. However, subcellular fractionation showed that this was not due to a significant recruitment of hVps34 or p150 from the cytosolic to the particulate fraction. These data suggest that the binding of Rab5 to the HEAT/WD40 domains of p150 is important in regulating the localization of hVps34/p150. However, Rab5 does not appear to act by directly recruiting p150/hVps34 complexes from the cytosol to the endosomal membrane.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010460     DOI: 10.1034/j.1600-0854.2002.30605.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  72 in total

Review 1.  ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39 drug discovery system.

Authors:  De-xin Kong; Takao Yamori
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

Review 2.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

Review 3.  Phosphoinositides and vesicular membrane traffic.

Authors:  Peter Mayinger
Journal:  Biochim Biophys Acta       Date:  2012-01-14

4.  Rab1a regulates sorting of early endocytic vesicles.

Authors:  Aparna Mukhopadhyay; Jose A Quiroz; Allan W Wolkoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-09       Impact factor: 4.052

Review 5.  Endosome maturation.

Authors:  Jatta Huotari; Ari Helenius
Journal:  EMBO J       Date:  2011-08-31       Impact factor: 11.598

Review 6.  Rab proteins and the compartmentalization of the endosomal system.

Authors:  Angela Wandinger-Ness; Marino Zerial
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-10-23       Impact factor: 10.005

Review 7.  Tied up: Does altering phosphoinositide-mediated membrane trafficking influence neurodegenerative disease phenotypes?

Authors:  Sravanthi S P Nadiminti; Madhushree Kamak; Sandhya P Koushika
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

8.  Class IA PI3K p110β subunit promotes autophagy through Rab5 small GTPase in response to growth factor limitation.

Authors:  Zhixun Dou; Ji-An Pan; Hashem A Dbouk; Lisa M Ballou; Jennifer L DeLeon; Yongjun Fan; Juei-Suei Chen; Zhimin Liang; Guangpu Li; Jonathan M Backer; Richard Z Lin; Wei-Xing Zong
Journal:  Mol Cell       Date:  2013-02-21       Impact factor: 17.970

9.  Structure and function of Vps15 in the endosomal G protein signaling pathway.

Authors:  Erin J Heenan; Janeen L Vanhooke; Brenda R Temple; Laurie Betts; John E Sondek; Henrik G Dohlman
Journal:  Biochemistry       Date:  2009-07-14       Impact factor: 3.162

10.  The late endosome is essential for mTORC1 signaling.

Authors:  Rory J Flinn; Ying Yan; Sumanta Goswami; Peter J Parker; Jonathan M Backer
Journal:  Mol Biol Cell       Date:  2010-01-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.